# Spexis Ltd

Spexis Ltd is an Asset Manager based in Allschwil, Switzerland.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Allschwil, Switzerland
- **Region:** Europe
- **Address:** Allschwil, Switzerland
- **Founded:** 2021
- **Assets under management:** Undisclosed
- **Website:** spexisbio.com

## Regulatory record

- **Reports private funds:** No

## Sectors

- Biotech
- Pharmaceuticals

## People

- Jeff Wager — Co-Founder & CEO

## Questions

### Who makes investment and development decisions at Spexis?

Jeff Wager, MD, serves as Co-Founder & CEO and leads strategic and operational decisions. He has built over $2B in biotech market value through prior ventures (per firm website).

### What therapeutic areas does Spexis pursue?

Spexis targets macrocycle therapeutics for infectious disease and oncology. Its platform aims to drug historically undruggable protein targets using macrocycles — larger than small molecules but smaller than biologics.

### What prior companies has Jeff Wager built?

Wager co-founded Grupo Biotoscana SL (IPO at $1B), Artisan Pharma (acquired by Asahi Kasei), and Enbiotix, among others. He also advised Zambon Group's €60M corporate venture fund (per firm website).

### Where is Spexis headquartered?

Spexis operates from Allschwil, Switzerland.

### Does Spexis have subsidiaries or affiliated entities?

The firm's website lists only the single entity 'Spexis Ltd.' No subsidiaries or parent structures are publicly disclosed.

## Related profiles

- [The Columbus Organization](https://altss.com/profile/the-columbus-organization)
- [Hardinge Inc.](https://altss.com/profile/hardinge-inc)

---

Last updated: 2026-05-31T00:00:06.779Z

Canonical page: https://altss.com/profile/spexis-ltd

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology